# Kyros Intel

> Chain-of-custody intelligence platform for the biologics industry.

Kyros Intel is an AI-powered software platform purpose-built for biologics manufacturing, tissue banking, blood banking, and tissue recovery agencies. The platform provides FDA 21 CFR Part 11 compliant digital signatures, AI-powered donor chart review, blockchain-verified chain of custody, real-time shipment tracking, CAPA management, equipment calibration monitoring, and audit-ready documentation.

## Key Features

- FDA 21 CFR Part 11 Digital Signatures
- AI-Powered Donor Chart Review (reduces manual review time by 95%)
- Blockchain Chain of Custody Tracking
- Real-Time Shipment Monitoring with IoT Sensors
- CAPA (Corrective and Preventive Action) Management
- Equipment Calibration & Environmental Monitoring
- Audit-Ready Documentation & Reporting
- AATB Standards Compliance

## Industries Served

- Tissue Recovery Agencies (CRAs): donor referral intake, authorization, surgical recovery, and processor shipment coordination
- Tissue Banks (including birth tissue, musculoskeletal, cardiovascular)
- Blood Banks & Cord Blood Banks
- Biologics Manufacturers
- Eye Banks
- Long-Term Storage Facilities
- Research & Development Labs

## Compliance

Kyros Intel is designed for compliance with FDA 21 CFR Part 11, AATB Standards, HIPAA, SOC 2, and cGMP/cGTP regulations.

## Company

- Founded: 2024
- Founder: William Grayson Bordano
- Location: San Antonio, TX, USA
- Website: https://kyrosintel.com
- Contact: kyrosintel@gmail.com | +1-210-284-2278

## JARVIS: Autonomous AI Compliance Agent

Kyros Intel's AI agent, JARVIS, is an autonomous compliance co-pilot for the biologics industry. JARVIS employs a multi-agent orchestration framework combining retrieval-augmented generation (RAG), formal regulatory verification, and blockchain-anchored audit trails. It automates donor eligibility determinations with 99.7% accuracy, reduces manual document review time by 95.3%, and maintains zero compliance deviations. JARVIS processes donor chart reviews in under 3 minutes (vs. 67 minutes manually) and generates FDA 21 CFR Part 11-compliant digital signatures with complete audit provenance. The system does not replace qualified professionals, it augments them by handling paperwork autonomously while humans retain final authority.

## Pages

- [Homepage](/): Overview of the Kyros Intel biologics compliance platform.
- [Platform](/platform): Features including AI chart review, chain of custody, CAPA, and shipment tracking.
- [AI Chart Review](/chart-review): Automated donor eligibility determination for tissue banks.
- [Pricing](/pricing): Transparent pricing tiers and ROI calculator.
- [Industries](/industries): Solutions for tissue recovery, tissue and blood banking, and R&D labs.
- [About](/about): Company background and mission.
- [Contact](/contact): Request a demo or contact sales.
- [Security](/security): Enterprise security architecture and controls.
- [Compliance](/compliance): FDA 21 CFR Part 11, HIPAA, AATB, and SOC 2 compliance details.
- [White Papers](/white-papers): Research publications on autonomous AI compliance and biologics.